Background: Lung cancer screening with low-dose computed tomography (CT) scanning (LDCT) is accepted as a screening tool, but its application to populations exposed to recognized occupational or environmental carcinogens is limited. We apply LDCT to a population with a predominantly nonoccupational exposure to a recognized human lung carcinogen, Libby amphibole asbestos (LA).
| METHODS
In 2012, CARD's ongoing surveillance program for LA-exposed workers and residents identified 1149 patients who met the following eligibility criteria: 50 to 84 years of age; more than 20 pack-years of cigarette smoking; were free of symptoms of lung cancer; and had evidence of asbestos-related disease on highresolution chest CT scan that was taken a mean of 32 months before invitation to the LDCT lung cancer screening program.
Evidence of asbestos-related disease on chest CT scan included bilateral interstitial fibrosis, pleural plaques, or lamellar pleural thickening. Patients who had nodules or suspected lung cancers on the prior high-resolution chest CT scan were referred to their treating physician for appropriate follow-up.
A 16 slice GE Lightspeed CT scanner was used to obtain chest images in accordance with the protocol of the International Early Lung Cancer Action Program (I-ELCAP; www.elcap.org), delivering 1 to 3 mSv of radiation. All LDCT images underwent an initial review by local radiologists, a secondary review by clinic physicians, and a final reading by experienced academic radiologists of I-ELCAP. The clinic physician consulted with I-ELCAP radiologists to reconcile any differences before dissemination of results to patients. Positive findings and diagnoses of lung cancer were reviewed by a regional multidisciplinary tumor board for therapeutic recommendations. Nodule identification and follow-up were based on I-ELCAP protocols (www.elcap.org). Lung cancer was verified on the pathology report (with the exception of two cases, as noted in the Section 3).
Outreach for the program was conducted by newsletter, individual recruitment letters sent to those who met the eligibility criteria, and at routine clinic visits. Those who entered the program were educated about smoking cessation, and lung cancer risk.
Participants who had a baseline scan were offered annual scanning. and smoking characteristics of LDCT participants and nonparticipants are shown in Table 1 . Most participants were women (65%) and had environmental (59%) or household (25%) exposure to LA. Participants were exposed to LA for shorter duration and were more likely to have had environmental exposure to LA than nonparticipants.
Over half (56%) of the participants had more than the baseline CT depending on when they entered the program. Two hundred and forty-two participants had only one LDCT, 213 had two LDCTs, 102 had three LDCTs, and 10 had four LDCTs. Participants were added or dropped out of the screening at will as it was offered and encouraged as a free preventative health service.
Seventeen lung cancers were identified in the enrolled population of 567 people ( Table 2 ). The screening yield (number of cancers among people screened, expressed as a percentage) was 1.9% (11 of 567) at baseline scan, 1.5% (5 of 325) at first annual scan, 0.99% (1 of 102) at second annual scan, and 0 at the third (0 of 10) annual scan.
The stage distribution at diagnosis was: 10 cancers at stage 1; two cancers at stage 2; three cancers at stages 3 to 4; and two cancers were limited small-cell cancers.
Fifteen of the lung cancer cases underwent a confirmatory CTguided needle biopsy before treatment. The remaining two patients exhibited nodule growth consistent with stage 1A non-small-cell lung cancer and had fluorodeoxyglucose avidity on positron emission tomography scan. These two presumed cancers did not undergo biopsy and were treated with stereotactic body radiotherapy based on the local hospital multidisciplinary tumor board recommendation.
Cell type ( 17 providing empirical support for the use of the NCCN group 2 lung cancer-screening guidelines.
Indeed, application of the USPSTF criteria to our cohort would have left undetected over one-half of the lung cancers that we detected using our protocol.
Our study results are consistent with an increasing body of literature that supports the use of occupational or environmental risk factors as a determinant for lung cancer-screening eligibility.
Markowitz et al 4 screened 7189 former nuclear weapons workers
with occupational lung cancer risk and found that participants who met the NCCN group 2 eligibility criteria had a 1.36% screening yield on baseline CT scan, which was greater than the 1.0% screening yield on the NLST baseline scan. Welch et al 6 used LDCT screening of 1260 construction workers likely to be exposed to asbestos and other lung carcinogens. On LDCT scan, 26% of the population showed interstitial lung disease, and 20% had the pleural disease. At baseline, 21 lung cancers were detected for a screening yield of 1.6% similar to that of the NLST, despite the lesser smoking burden.
Indeed, only 43.5% of their participants met entry criteria for the NLST. The lung cancer stage distribution was favorable: 20 of the 26 (77%) of the non-small-cell lung cancers were stage I or II. 6 Brims et al 18 reported lung cancer screening of 906 asbestosexposed individuals in Wittenoom, Australia, 38% of who were exposed primarily to residential use of crocidolite. Screening participants were required to have radiographic evidence of pleural plaques or more than 3 months of occupational exposure. Over onethird of the study population never smoked, and the median smoking intensity was only 17.1 pack-years. This study is similar to the present one in the high frequency of residential exposure and in the use of radiographic evidence of ARPD. In this group, seven lung cancers were identified with LDCT. The prevalence of lung cancer was limited (0.77%), consistent with the much smaller smoking burden. None of the seven patients with lung cancer met the USPSTF guidelines, and all were early stage and treated by surgery with curative intent. 18 Recently, Italian investigators demonstrated that LDCT screening reduced the lung cancer mortality in shipyard workers exposed to asbestos when screened workers were compared with both regional and national rates and a nonscreened control group (0.55 vs 2.07). 19 A distinctive aspect of the current study is the predominance of environmental and household exposure rather than occupational exposure to asbestos. Indeed, the existing literature documenting excess lung cancer risk among populations environmentally or paraoccupationally exposed to asbestos is modest.
Yet, our lung cancer-screening yield of 1.9% on baseline scan and 1.5% on the first annual scan is comparable to the occupational studies noted above. 4, 6 Limitations of our study include a relatively small cohort;
incomplete annual scan compliance, a 49% participation rate, and lack of tissue confirmation in two cases of lung cancer. Ours was not a population-based sample but enrollees in an LA disease surveillance program, limiting its generalizability. Participants had a prior CT scan on average 2.5 years before the onset of the screening program, so slow-growing lung cancers may have already been detected at a prior scan, lowering the screening yield of our program.
In conclusion, current study results add to growing evidence that environmental or occupational exposure to lung carcinogens can usefully be included in eligibility criteria for lung cancer screening, expanding the population that can benefit from low-dose CT screening for lung cancer.
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